JAZZ Stock Recent News

JAZZ LATEST HEADLINES

JAZZ Stock News Image - zacks.com

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Jazz Pharmaceuticals (JAZZ) and argenex SE (ARGX). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com 2025 Mar 31
JAZZ Stock News Image - prnewswire.com

DUBLIN , March 26, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 24th Annual Needham Healthcare Conference. Company management will participate in a fireside chat on Wednesday, April 9, 2025, at 9:45 a.m.

prnewswire.com 2025 Mar 26
JAZZ Stock News Image - zacks.com

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com 2025 Mar 24
JAZZ Stock News Image - zacks.com

MPLX, LDOS, JAZZ, FTNT and PPC are some of the stocks with high ROE to profit from as markets falter on tariff concerns.

zacks.com 2025 Mar 21
JAZZ Stock News Image - zacks.com

Here are four discounted PEG stocks, JAZZ, FMS, DAN and ITRI, which qualify our screening criteria.

zacks.com 2025 Mar 20
JAZZ Stock News Image - zacks.com

The average of price targets set by Wall Street analysts indicates a potential upside of 38.9% in Jazz (JAZZ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

zacks.com 2025 Mar 19
JAZZ Stock News Image - prnewswire.com

Updated top-line results demonstrate improved outcomes in adults with narcolepsy or idiopathic hypersomnia treated with Xywav as observed in the Phase 4 DUET (Developing Understanding of Hypersomnia by Evaluating Low-Sodium Oxybate Treatment) study Novel analysis of real-world Epidiolex treatment patterns underscore importance of dose optimization for improved patient persistence For U.S. media and investors only DUBLIN , March 19, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that seven abstracts from across its neuroscience portfolio will be featured at the 77th Annual American Academy of Neurology Meeting (AAN) being held April 5-9, 2025, in San Diego. Data presented at the meeting includes an updated presentation of top-line results of the open-label, single-arm, Phase 4 DUET (Develop hypersomnia Understanding by Evaluating low-sodium oxybate Treatment) trial, evaluating the effectiveness and safety of low-sodium oxybate, Xywav® (calcium,

prnewswire.com 2025 Mar 19
JAZZ Stock News Image - zacks.com

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Illumina (ILMN). But which of these two stocks is more attractive to value investors?

zacks.com 2025 Mar 14
JAZZ Stock News Image - zacks.com

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com 2025 Mar 14
JAZZ Stock News Image - zacks.com

Despite a correction to begin the year, there are a few pockets of the market that are working.

zacks.com 2025 Mar 13
10 of 50